Cargando…
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma
Genomic analysis could contribute to a better understanding of the biological determinants of the evolution of multiple myeloma (MM) precursor disease and an improved definition of high-risk patients. To assess the feasibility and value of next-generation sequencing approaches in an asymptomatic set...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281620/ https://www.ncbi.nlm.nih.gov/pubmed/32456143 http://dx.doi.org/10.3390/cancers12051332 |
_version_ | 1783543963301445632 |
---|---|
author | Manzoni, Martina Marchica, Valentina Storti, Paola Ziccheddu, Bachisio Sammarelli, Gabriella Todaro, Giannalisa Pelizzoni, Francesca Salerio, Simone Notarfranchi, Laura Pompa, Alessandra Baldini, Luca Bolli, Niccolò Neri, Antonino Giuliani, Nicola Lionetti, Marta |
author_facet | Manzoni, Martina Marchica, Valentina Storti, Paola Ziccheddu, Bachisio Sammarelli, Gabriella Todaro, Giannalisa Pelizzoni, Francesca Salerio, Simone Notarfranchi, Laura Pompa, Alessandra Baldini, Luca Bolli, Niccolò Neri, Antonino Giuliani, Nicola Lionetti, Marta |
author_sort | Manzoni, Martina |
collection | PubMed |
description | Genomic analysis could contribute to a better understanding of the biological determinants of the evolution of multiple myeloma (MM) precursor disease and an improved definition of high-risk patients. To assess the feasibility and value of next-generation sequencing approaches in an asymptomatic setting, we performed a targeted gene mutation analysis and a genome-wide assessment of copy number alterations (CNAs) by ultra-low-pass whole genome sequencing (ULP-WGS) in six patients with monoclonal gammopathy of undetermined significance and 25 patients with smoldering MM (SMM). Our comprehensive genomic characterization highlighted heterogeneous but substantial values of the tumor fraction, especially in SMM; a rather high degree of genomic complexity, in terms of both mutations and CNAs, and inter-patient variability; a higher incidence of gene mutations and CNAs in SMM, confirming ongoing evolution; intraclonal heterogeneity; and instances of convergent evolution. ULP-WGS of these patients proved effective in revealing the marked genome-wide level of their CNAs, most of which are not routinely investigated. Finally, the analysis of our small SMM cohort suggested that chr(8p) deletions, the DNA tumor fraction, and the number of alterations may have clinical relevance in the progression to overt MM. Although validation in larger series is mandatory, these findings highlight the promising impact of genomic approaches in the clinical management of SMM. |
format | Online Article Text |
id | pubmed-7281620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72816202020-06-17 Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma Manzoni, Martina Marchica, Valentina Storti, Paola Ziccheddu, Bachisio Sammarelli, Gabriella Todaro, Giannalisa Pelizzoni, Francesca Salerio, Simone Notarfranchi, Laura Pompa, Alessandra Baldini, Luca Bolli, Niccolò Neri, Antonino Giuliani, Nicola Lionetti, Marta Cancers (Basel) Article Genomic analysis could contribute to a better understanding of the biological determinants of the evolution of multiple myeloma (MM) precursor disease and an improved definition of high-risk patients. To assess the feasibility and value of next-generation sequencing approaches in an asymptomatic setting, we performed a targeted gene mutation analysis and a genome-wide assessment of copy number alterations (CNAs) by ultra-low-pass whole genome sequencing (ULP-WGS) in six patients with monoclonal gammopathy of undetermined significance and 25 patients with smoldering MM (SMM). Our comprehensive genomic characterization highlighted heterogeneous but substantial values of the tumor fraction, especially in SMM; a rather high degree of genomic complexity, in terms of both mutations and CNAs, and inter-patient variability; a higher incidence of gene mutations and CNAs in SMM, confirming ongoing evolution; intraclonal heterogeneity; and instances of convergent evolution. ULP-WGS of these patients proved effective in revealing the marked genome-wide level of their CNAs, most of which are not routinely investigated. Finally, the analysis of our small SMM cohort suggested that chr(8p) deletions, the DNA tumor fraction, and the number of alterations may have clinical relevance in the progression to overt MM. Although validation in larger series is mandatory, these findings highlight the promising impact of genomic approaches in the clinical management of SMM. MDPI 2020-05-23 /pmc/articles/PMC7281620/ /pubmed/32456143 http://dx.doi.org/10.3390/cancers12051332 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Manzoni, Martina Marchica, Valentina Storti, Paola Ziccheddu, Bachisio Sammarelli, Gabriella Todaro, Giannalisa Pelizzoni, Francesca Salerio, Simone Notarfranchi, Laura Pompa, Alessandra Baldini, Luca Bolli, Niccolò Neri, Antonino Giuliani, Nicola Lionetti, Marta Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma |
title | Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma |
title_full | Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma |
title_fullStr | Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma |
title_full_unstemmed | Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma |
title_short | Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma |
title_sort | application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281620/ https://www.ncbi.nlm.nih.gov/pubmed/32456143 http://dx.doi.org/10.3390/cancers12051332 |
work_keys_str_mv | AT manzonimartina applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT marchicavalentina applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT stortipaola applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT ziccheddubachisio applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT sammarelligabriella applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT todarogiannalisa applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT pelizzonifrancesca applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT saleriosimone applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT notarfranchilaura applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT pompaalessandra applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT baldiniluca applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT bolliniccolo applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT neriantonino applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT giulianinicola applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma AT lionettimarta applicationofnextgenerationsequencingforthegenomiccharacterizationofpatientswithsmolderingmyeloma |